NASDAQ:IMNN News | QuoteStream

globenewswire

IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development

Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanismFirst-of-its-kind meeting spotlights IMNN-001 as one of the novel technologies shaping the future of cancer drug discovery and developmentLA…

GlobeNewswire en 7/23/2026, 09:25 PM GMT+8

ETFsStocksUS

IMNN

dow-jones

Imunon CFO Jeffrey Church Retires

Dow Jones Newswires en 7/1/2026, 06:15 AM GMT+8

StocksUS

IMNN

reuters

Imunon - Jeffrey Church To Retire As Interim CFO Effective July 1, 2026 - SEC Filing

Imunon Inc NASDAQ:IMNN:

Reuters en 7/1/2026, 05:32 AM GMT+8

StocksUS

IMNN

tradingview

Imunon CFO Jeffrey Church to Retire; Josh Blacher Named Interim CFO

Imunon’s interim Chief Financial Officer Jeffrey Church will retire effective July 1, 2026, and Josh Blacher will be appointed interim Chief Financial Officer effective the same date.Original SEC Filing: Imunon, Inc. [ IMNN ] - 8-K - Jun. 30, 2026This is an AI-powered summary. It may contain inaccu…

TradingView en 7/1/2026, 04:33 AM GMT+8

StocksUS